Research Article

Altered Expression of Three EGFR Posttranslational Regulators MDGI, MIG6, and EIG121 in Invasive Breast Carcinomas

Figure 2

Results of MDGI, MIG6, and EIG121 confirmed at a protein level by using IHC in a population of invasive breast carcinomas (). Protein underexpression of the 3 inhibitors is identified in 19.4% (MDGI), 43.2% (MIG6) and 19.4% (EIG121). Interestingly, EIG121 underexpression is observed in 61.1% of the TNC subtype and MIG6 underexpression in 55.3% of the HR+/HER2- subtype.